Pelizaeus-Merzbacher Disease as a Cause of Early-Onset Developmental Delay: A Case Report

Pelizaeus-Merzbacher disease (PMD) is a rare X-linked hypomyelinating leukodystrophy disorder caused by a mutation in the proteolipid protein 1 (PLP1) gene which is responsible for myelin formation in the central nervous system. We report a case of PMD in a male patient who initially presented with developmental delay at three months and was ultimately diagnosed at 10 years and 7 months of age. We aim to describe the initial presentation, clinical course of PMD and the investigations that aid in diagnosis so that future cases may be identified earlier. During the investigative workup of our patient, a deletion of exon 16 - an extremely rare heterozygous nucleotide variation, c.330C>T (p.D110D) - was identified, the pathogenicity of which has not been previously documented in the literature. In our report, we also aim to highlight the potential use of biotin in improving symptoms in such patients as there is currently no curative treatment available.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-04-15
DOI
https://doi.org/10.7759/cureus.82308
Primary Topic
Neuroscience of respiration and sleep
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pelizaeus-Merzbacher Disease as a Cause of Early-Onset Developmental Delay: A Case Report

Doriette Soler, Michela Galea, Miriana Cocker, Esther Bezzina
Cureus
Neuroscience of respiration and sleep
article

Pelizaeus-Merzbacher Disease as a Cause of Early-Onset Developmental Delay: A Case Report

Doriette Soler, Michela Galea, Miriana Cocker, Esther Bezzina
article en

Abstract

Pelizaeus-Merzbacher disease (PMD) is a rare X-linked hypomyelinating leukodystrophy disorder caused by a mutation in the proteolipid protein 1 (PLP1) gene which is responsible for myelin formation in the central nervous system. We report a case of PMD in a male patient who initially presented with developmental delay at three months and was ultimately diagnosed at 10 years and 7 months of age. We aim to describe the initial presentation, clinical course of PMD and the investigations that aid in diagnosis so that future cases may be identified earlier. During the investigative workup of our patient, a deletion of exon 16 - an extremely rare heterozygous nucleotide variation, c.330C>T (p.D110D) - was identified, the pathogenicity of which has not been previously documented in the literature. In our report, we also aim to highlight the potential use of biotin in improving symptoms in such patients as there is currently no curative treatment available.

CureusVol. 17(4)
Mater Dei Hospital (MT)
Openalex Percentile: Top 92%
Neuroscience of respiration and sleep
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Pelizaeus-Merzbacher Disease as a Cause of Early-Onset Developmental Delay: A Case Report — Doriette Soler, Michela Galea, et al. · Cureus (2025) | TGRS Research Map | TGRS